Is newly diagnosed type 2 diabetes treated according to the guidelines? Results of the Polish ARETAEUS1 study
There is a paucity of data on meeting treatment goals in patients with newly diagnosed type 2 diabetes (DM2). The aim of the study was to characterize Polish patients with newly diagnosed DM2, to assess management of hyperglycemia, and to estimate the proportion of patients achieving the criteria of...
Gespeichert in:
Veröffentlicht in: | Polskie archiwum medycyny wewne̦trznej 2011-01, Vol.121 (1-2), p.7 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | There is a paucity of data on meeting treatment goals in patients with newly diagnosed type 2 diabetes (DM2).
The aim of the study was to characterize Polish patients with newly diagnosed DM2, to assess management of hyperglycemia, and to estimate the proportion of patients achieving the criteria of disease control recommended by the national clinical practice guidelines published in 2008.
ARETAEUS1 was a cross-sectional questionnaire-based study conducted in several regions of Poland in 2009 (January-April). It involved 1714 patients with DM2 of any age and sex, treated for less than 24 months, and recruited by randomly selected physicians.
Only 28.9% of patients with DM2 met the goal for glycated hemoglobin (HbA1c) control ( |
---|---|
ISSN: | 1897-9483 |